Sinocelltech Group

Sinocelltech Group EBITDA per Employee

EBITDA per Employee of Sinocelltech Group (688520.SS) as of Oct 25, 2026.

EBITDA per Employee

-CNY

Last updated:

EBITDA per Employee of Sinocelltech Group is 2026 - CNY. EBITDA per Employee of Sinocelltech Group was 2025 - CNY. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sinocelltech Group Stock analysis

What does Sinocelltech Group do? Sinocelltech Group Ltd, based in Beijing, China, operates in the Health Care sector with a focus on biotechnology. The company develops and manufactures biopharmaceutical products, including monoclonal antibodies, recombinant proteins, and vaccines. Key products are SCT800, SCT200, SCT-I10A, SCT400, SCT510, SCT1000, and SCT630. Sinocelltech employs 1,868 full-time staff and is listed on the stock market since June 22, 2020. It also engages in asset leasing and payment collection services. Sinocelltech Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sinocelltech Group stock

On Eulerpool you can find the complete historical development of EBITDA per Employee Sinocelltech Group since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Sinocelltech Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Sinocelltech Group

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Sinocelltech Group